Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fibroid Treatment May Offer Hope for Women Who Want to Conceive

23.11.2004


National Security Advisor Condoleezza Rice today underwent embolization—a non-surgical treatment to kill uterine fibroid tumors. While embolization is a good option for some patients, a less invasive option is on the horizon, as outlined this week in the American Journal of Obstetrics and Gynecology.



The new procedure could someday replace both embolization and the even more invasive hysterectomy, especially for patients who would still like to have children after treatment, according to Dr. Ayman Al-Hendy, assistant professor of obstetrics and gynecology at the University of Texas Medical Branch at Galveston and lead investigator on the study. “Patients who undergo embolization should not conceive after treatment,” Al-Hendy says. “After the tumor is killed, the particles placed in the blood vessels continue blocking blood flow to the uterus, which could lead to miscarriages or even birth defects.”

Al-Hendy and his colleagues have devised a less invasive treatment, which involves stripping estrogen receptors from tumor cells. Without estrogen, these cells stop growing and eventually die. Researchers believe patients who undergo this new procedure would still be able to safely conceive.


Fibroid tumors afflict 20 to 40 percent of women over age 35 and can cause pelvic pain, complications for pregnancy and heavy menstrual bleeding. Of the 600,000 hysterectomies performed each year in the United States, one-third are due to uterine fibroid tumors. Fibroid tumors of the uterus are the most common tumors found in the female genital tract.

Al-Hendy points out that embolization is a great alternative to hysterectomy for many women. But it only helps those with few or small-sized tumors. Currently, hysterectomy is the only viable solution for women with multiple or large fibroids.

Al-Hendy and his team believe that this research could eventually lead to safe, non-surgical treatment of fibroids for nearly all women affected by these painful tumors. He predicts clinical studies will be underway in about three to four years.

Joining Al-Hendy in the study were Dr. Eun J. Lee from Northwestern University Feinberg School of Medicine in Chicago, Ill., and Drs. Hui Q. Wang and John A. Copland, both faculty members at UTMB.

The University of Texas Medical Branch at Galveston
Public Affairs Office
301 University Boulevard, Suite 3.102
Galveston, Texas 77555-0144

| newswise
Further information:
http://www.utmb.edu

More articles from Health and Medicine:

nachricht UC San Diego researchers develop sensors to detect and measure cancer's ability to spread
06.12.2018 | University of California - San Diego

nachricht New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories
05.12.2018 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

Im Focus: Substitute for rare earth metal oxides

New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals

Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.

Im Focus: A bit of a stretch... material that thickens as it's pulled

Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.

Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...

Im Focus: The force of the vacuum

Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.

The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

Expert Panel on the Future of HPC in Engineering

03.12.2018 | Event News

Inaugural "Virtual World Tour" scheduled for december

28.11.2018 | Event News

 
Latest News

A new molecular player involved in T cell activation

07.12.2018 | Life Sciences

High-temperature electronics? That's hot

07.12.2018 | Materials Sciences

Supercomputers without waste heat

07.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>